Minnesota's 30-day warning period for privacy violations expired January 31, giving the attorney general free rein to sue companies over misuse of residents' health data, which can draw penalties up to $7,500 per violation.
Medtronic's FDA-cleared Nellcor pulse oximetry system with its new Nell-EQ processor is designed to deliver accurate oxygen readings across all skin tones, addressing a bias problem that drew intense scrutiny during the COVID-19 pandemic.
CapsoVision's AI Highlights, cleared by the FDA on September 25, 2026, scans tens of thousands of capsule endoscopy frames to flag suspected small bowel bleeding lesions for physician review.
BMW's 2026 iX3 becomes the first production car to run Amazon's Alexa+ generative-AI assistant, the result of a three-year partnership, rolling out in Germany and the U.S. by late 2026 even as privacy advocates question how much driving data reaches Amazon's servers.
Kintsugi, a Berkeley AI startup that raised $30 million to detect depression from voice patterns, shut down commercial operations in February 2026 after years in FDA review and open-sourced its technology on Hugging Face.
Google retired the Fitbit app brand on May 19, 2026, relaunching it as Google Health with a Gemini-powered AI coaching assistant bundled into a new $9.99-a-month Premium tier and a $99.99 screenless Fitbit Air tracker.
Sleep Cycle is validating an AI tool that screens for obstructive sleep apnea using only an iPhone's microphone, targeting the estimated 950 million adults worldwide with the condition, nearly 80% of whom remain undiagnosed.
The FDA has cleared TREWS, the first continuous AI sepsis monitor, after a Nature Medicine study of 764,707 patient encounters found an 18% relative drop in mortality when clinicians acted on its alerts, which can flag sepsis up to 48 hours before clinical suspicion.
Aidoc's CARE Body CT Multi-Triage won FDA clearance in January 2026 as the first comprehensive foundation-model AI for broad clinical triage, flagging 14 urgent conditions from one CT scan with 97% mean sensitivity, and Medicare is already paying hospitals up to $137.53 per case to use it.
Novo Nordisk announced September 16, 2026 that it is deploying Anthropic's Claude models and Claude Science research platform across its drug discovery workflows, part of three AI partnerships the company struck within a single 72-hour span.